Search

Search Constraints

You searched for: Author/Creator Kurosaki, Masayuki

Search Results

41. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. Issue 10 (8th July 2021)

42. Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality. Issue 3 (19th December 2021)

43. Long‐term follow up of peginterferon‐α‐2a treatment of hepatitis B e‐antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies. Issue 10 (18th January 2016)

45. Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated‐interferon plus ribavirin therapy for chronic hepatitis C1. Issue 3 (7th January 2013)

46. Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy. Issue 10 (October 2015)

48. Non‐alcoholic fatty liver disease fibrosis score and FIB‐4 scoring system could identify patients at risk of systemic complications. Issue 6 (15th October 2014)

49. Non‐invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection. Issue 1 (26th December 2018)

50. Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis. Issue 5 (13th May 2023)